These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4452430)

  • 1. Effectiveness of the intestinal polypeptides, IRP, GIP, VIP and motilin on insulin release in the rat.
    Turner DS; Etheridge L; Marks V; Brown JC; Mutt V
    Diabetologia; 1974 Oct; 10(5):459-63. PubMed ID: 4452430
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adrenaline on insulin releasing polypeptide (IRP) mediated insulin release in vivo in the rat.
    Shabaan A; Turner DS; Marks V
    Diabetologia; 1974 Oct; 10(5):475-8. PubMed ID: 4452433
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained insulin release in response to intravenous infusion of insulin releasing polypeptide (IRP) in the rat.
    Shabaan AA; Turner DS; Marks V
    Diabetes; 1974 Nov; 23(11):902-4. PubMed ID: 4430417
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of the intestinal polypeptides, IRP and GIP, on insulin release and glucose tolerance in the baboon.
    Turner DS; Etheridge L; Jones J; Marks V; Meldrum B; Bloom SR; Brown JC
    Clin Endocrinol (Oxf); 1974 Oct; 3(4):489-93. PubMed ID: 4430150
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
    Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
    Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption.
    Ebert R; Unger H; Creutzfeldt W
    Diabetologia; 1983 Jun; 24(6):449-54. PubMed ID: 6350081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin secretory effect of the human duodenal mucosa.
    Fasel J; Hadjikhani H; Felber JP
    Gastroenterology; 1970 Jul; 59(1):109-13. PubMed ID: 5426981
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of gastrointestinal hormones on insulin and glucagon secretion.
    Creutzfeldt W; Feurle G; Ketterer H
    N Engl J Med; 1970 May; 282(20):1139-41. PubMed ID: 4909197
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Tatemoto K; Efendić S
    Endocrinology; 1983 Apr; 112(4):1469-73. PubMed ID: 6339205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction of vasoactive intestinal polypeptide (VIP), glucose and arginine on the secretion of insulin, glucagon and somatostatin in the perfused rat pancreas.
    Szecówka J; Sandberg E; Efendić S
    Diabetologia; 1980 Aug; 19(2):137-42. PubMed ID: 6106616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of short and long term chlorpropamide treatment of insulin release and blood-glucose.
    Barnes AJ; Garbien KJ; Crowley MF; Bloom A
    Lancet; 1974 Jul; 2(7872):69-72. PubMed ID: 4136696
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of gut hormone on insulin and glucagon secretion].
    Ohneda A; Ketterer H; Eisentraut AM; Unger RH
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():191-203. PubMed ID: 4907220
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of gut peptides on glucose-stimulated insulin release by monolayer cultures of neonatal rat islet cells.
    Fujimoto WY
    Horm Metab Res; 1981 Mar; 13(3):135-8. PubMed ID: 7016701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas.
    Schäfer R; Schatz H
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):493-500. PubMed ID: 382725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulinotropic action of gastric inhibitory polypeptide.
    Pederson RA; Schubert HE; Brown JC
    Can J Physiol Pharmacol; 1975 Apr; 53(2):217-23. PubMed ID: 1137819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin response to glucagon. The opposing effects of diabetes and obesity.
    Crockford PM; Hazzard WR; Williams RH
    Diabetes; 1969 Apr; 18(4):216-24. PubMed ID: 5776458
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of gastric inhibitory polypeptide (GIP) and cholecystokinin (CCK-8) with basal and stimulated insulin secretion in mice.
    Ahrén B; Hedner P; Lundquist I
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):96-102. PubMed ID: 6130663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
    Nauck MA; Wollschläger D; Werner J; Holst JJ; Orskov C; Creutzfeldt W; Willms B
    Diabetologia; 1996 Dec; 39(12):1546-53. PubMed ID: 8960841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric inhibitory polypeptide: effect on glucose-induced insulin release from isolated rat pancreatic islets in vitro.
    Schauder P; Brown JC; Frerichs H; Creutzfeldt W
    Diabetologia; 1975 Oct; 11(5):483-4. PubMed ID: 1103369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.